{
  "ticker": "LLY",
  "target_date": "2025-11-18",
  "actual_date": "2025-11-18",
  "collected_at": "2025-12-08T12:32:59.896100",
  "price": {
    "open": 1014.01,
    "high": 1040.72,
    "low": 1014.01,
    "close": 1030.050048828125,
    "volume": 3430500,
    "change_1d_pct": 0.82,
    "change_7d_pct": 11.6,
    "change_30d_pct": 22.28
  },
  "technicals": {
    "rsi_14": 93.37,
    "sma_20": 913.4,
    "sma_50": 837.15,
    "macd": 58.373,
    "macd_signal": 47.382,
    "macd_histogram": 10.991,
    "bb_upper": 1079.48,
    "bb_lower": 747.32,
    "price_vs_sma20_pct": 12.77,
    "price_vs_sma50_pct": 23.04,
    "volume_ratio": 0.78
  },
  "fundamentals": {
    "market_cap": 892319629312,
    "pe_ratio": 48.769478,
    "forward_pe": 43.926964,
    "price_to_book": 37.476845,
    "price_to_sales": 15.01721,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.49,
    "pct_from_52w_low": 59.57
  },
  "macro": {
    "spy": {
      "price": 660.08,
      "change_1d_pct": -0.84,
      "change_7d_pct": -3.13
    },
    "vix": {
      "level": 24.69,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.12
    },
    "dollar_index": {
      "level": 99.55
    },
    "gold": {
      "price": 4061.3
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Lilly Stock Continues Its Winning Ways",
      "source": "Yahoo",
      "datetime": 1763502067,
      "summary": "Eli Lilly shares rose again Tuesday, their sixth increase in the past seven sessions. The drugmaker's market cap also closed at a record, $973.8 billion, as Lilly inched closer to the $1 trillion market cap milestone.",
      "url": "https://finnhub.io/api/news?id=025e44ff9087b7b6110d380fdb41892dc7f0f1c43a3a82b3e893e863f5a39746"
    },
    {
      "headline": "Top Research Reports for Microsoft, Amazon.com & Eli Lilly",
      "source": "Yahoo",
      "datetime": 1763500320,
      "summary": "Microsoft shines in Zacks' top picks as strong cloud and AI momentum drive standout quarterly results and reinforce long-term growth potential.",
      "url": "https://finnhub.io/api/news?id=10c96fd91f5464159be7e3296aaaec26bc3fcbf815c86129a15cdef3ed4643a4"
    },
    {
      "headline": "Tracking Jeremy Grantham's GMO Capital Portfolio - Q3 2025 Update",
      "source": "SeekingAlpha",
      "datetime": 1763494170,
      "summary": "GMO's Q3 2025 13F portfolio rose to $35.46B, with Microsoft, Alphabet, Meta, Apple, and Lam Research as top holdings. Learn more about the portfolio here.",
      "url": "https://finnhub.io/api/news?id=b05438074d046bb3e4c76ce9412b9f313458cdfe24056dbddb7b2b3d89563f27"
    },
    {
      "headline": "Lilly's Donanemab Wins India Approval For Alzheimer's",
      "source": "Yahoo",
      "datetime": 1763490994,
      "summary": "Launch coming soon as India waits on final pricing plans",
      "url": "https://finnhub.io/api/news?id=2695528c56ad953a58de7461a1fad2e7850aafa814e32a692a264525847746e0"
    },
    {
      "headline": "RHHBY Reports Positive Phase III Data on Breast Cancer Drug",
      "source": "Yahoo",
      "datetime": 1763490180,
      "summary": "Roche reports strong phase III lidERA results as giredestrant delivers meaningful iDFS gains over standard endocrine therapy.",
      "url": "https://finnhub.io/api/news?id=149690d6484fd0dd5380f8356316f66af21252d368d90fb740a04b74ed0aef44"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-11-18",
      "description": "xslF345X05/wk-form4_1763501994.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000269/xslF345X05/wk-form4_1763501994.xml"
    },
    {
      "form": "4",
      "date": "2025-11-18",
      "description": "xslF345X05/wk-form4_1763501198.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000126238825000008/xslF345X05/wk-form4_1763501198.xml"
    },
    {
      "form": "4",
      "date": "2025-11-18",
      "description": "xslF345X05/wk-form4_1763501099.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000266/xslF345X05/wk-form4_1763501099.xml"
    },
    {
      "form": "4",
      "date": "2025-11-18",
      "description": "xslF345X05/wk-form4_1763501018.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000264/xslF345X05/wk-form4_1763501018.xml"
    },
    {
      "form": "4",
      "date": "2025-11-18",
      "description": "xslF345X05/wk-form4_1763500905.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000155171525000006/xslF345X05/wk-form4_1763500905.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}